Clinical Trials Browser

Phase 1/2 × Active not recruiting × Lymphoma, Extranodal NK-T-Cell × Clear all

NCT05627856 2025-09-26

A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

Phase 1/2 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Extranodal NK-T-Cell